PerkinElmer, Inc.
PKI
Hisse Senetlerindeki Sıralama
#1429
PerkinElmer, Inc. operates as a global enterprise delivering innovative... PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Hisse Fiyatı
$120.30
Son senkronizasyon: 2023-05-23
Piyasa Değeri
$15.17B
Değişim (1 gün)
0.05%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret PerkinElmer, Inc. (PKI)
Kategori
Healthcare
PerkinElmer, Inc. (PKI) için tedavüldeki hisse sayısı
October 2026 itibarıyla tedavüldeki hisse sayısı: 0
PerkinElmer, Inc. şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 0'dir. October 2026 sonunda şirketin 0 tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
PerkinElmer, Inc. (PKI) için 2001 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2025 | 116.60M | -4.02% |
| 2024 | 121.47M | -3.71% |
| 2023 | 126.16M | 8.60% |
| 2022 | 116.17M | 4.17% |
| 2021 | 111.51M | 0.62% |
| 2019 | 110.83M | 0.24% |
| 2018 | 110.56M | 0.64% |
| 2017 | 109.86M | -2.36% |
| 2016 | 112.51M | -0.08% |
| 2014 | 112.59M | 0.30% |
| 2013 | 112.25M | -1.30% |
| 2012 | 113.73M | -2.89% |
| 2011 | 117.11M | 0.74% |
| 2010 | 116.25M | -1.20% |
| 2008 | 117.66M | -0.82% |
| 2007 | 118.64M | -4.76% |
| 2006 | 124.57M | -2.73% |
| 2005 | 128.06M | 1.56% |
| 2003 | 126.09M | 0.42% |
| 2002 | 125.57M | 20.09% |
| 2001 | 104.56M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| 370.00M | - |
US
|
|
| 703.80M | - |
US
|
|
| 143.28M | - |
US
|
|
| - | - |
CN
|
|
| 282.00M | - |
US
|
